Pharma Co. Asks For Stay To Appeal 'Orange Book' Delisting

By Kelly Lienhard (November 23, 2022, 4:38 PM EST) -- Jazz Pharmaceuticals has asked a Delaware federal court to pause an order requiring it to ask the U.S. Food and Drug Administration to pull a patent that purportedly covers the distribution of a narcolepsy drug from the agency's so-called Orange Book while it appeals....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!